{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:39:59Z","timestamp":1779914399897,"version":"3.53.1"},"reference-count":15,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Royal Prince Alfred Hospital Mpox Vaccination Clinic opened in response to the 2022 multicountry mpox outbreak. A total of 9500 vaccinations were administered intradermally and subcutaneously during the first 16\u2009weeks of clinic operation. The rate of adverse events was 0.1%. Compared to people who received the vaccine intradermally, those who received it subcutaneously were more likely to be aged 30\u201339\u2009years (<jats:italic>P<\/jats:italic> =\u20090.047), sexual partners of gay and bisexual men (<jats:italic>P<\/jats:italic> &lt;\u20090.001), eligible for Medicare (<jats:italic>P<\/jats:italic> &lt;\u20090.001) and born in the Philippines (<jats:italic>P<\/jats:italic> =\u20090.01) or Malaysia (<jats:italic>P<\/jats:italic> =\u20090.04).<\/jats:p>","DOI":"10.1111\/imj.16386","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T09:29:49Z","timestamp":1713864589000},"page":"1031-1034","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mpox vaccination routes: prevalence, correlates and adverse effects of subcutaneous versus intradermal vaccination at a mass vaccination clinic in Sydney, Australia"],"prefix":"10.1111","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0016-8319","authenticated-orcid":false,"given":"Alisa","family":"Pollack","sequence":"first","affiliation":[{"name":"Vaccination Clinic Royal Prince Alfred Hospital  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Lo","sequence":"additional","affiliation":[{"name":"Vaccination Clinic Royal Prince Alfred Hospital  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaho","family":"Imamura","sequence":"additional","affiliation":[{"name":"Vaccination Clinic Royal Prince Alfred Hospital  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Caterson","sequence":"additional","affiliation":[{"name":"Vaccination Clinic Royal Prince Alfred Hospital  Sydney New South Wales Australia"},{"name":"Boden Collaboration Charles Perkins Centre, The University of Sydney  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"e_1_2_3_2_1","unstructured":"World Health Organization.Mpox (Monkeypox). World Health Organization. Updated 18 April 2023. Available from URL:https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/monkeypox."},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2208860"},{"key":"e_1_2_3_4_1","unstructured":"Commonwealth of Australia.Mpox (Monkeypox). Department of Health and Aged Care. Updated 29 September 2022. Available from URL:https:\/\/www.health.gov.au\/diseases\/monkeypox-mpox."},{"key":"e_1_2_3_5_1","unstructured":"World Health Organization.Multi\u2010Country Outbreak of Mpox External Situation Report #31 \u2013 22 December 2023. World Health Organization. Published 22 December 2023. Available from URL:https:\/\/www.who.int\/publications\/m\/item\/multi-country-outbreak-of-mpox--external-situation-report-31---22-december-2023."},{"key":"e_1_2_3_6_1","unstructured":"National Notifiable Disease Surveillance System.National Communicable Disease Surveillance Dashboard. Department of Health and Aged Care. Updated 2 February 2024. Available from URL:https:\/\/nindss.health.gov.au\/pbi-dashboard\/."},{"key":"e_1_2_3_7_1","unstructured":"NSW Government.Week 33 14 to 20 August 2022. Communicable Diseases Weekly Report. Published 20 August 2022. Available from URL:https:\/\/www.health.nsw.gov.au\/Infectious\/Reports\/Publications\/cdwr\/2022\/cdwr-week-33-2022.pdf."},{"key":"e_1_2_3_8_1","unstructured":"ATAGI.ATAGI Clinical Guidance on Vaccination against Monkeypox Version 4.0. Department of Health and Aged Care. Published 12 December 2022. Available from URL:https:\/\/www.health.gov.au\/resources\/publications\/atagi-clinical-guidance-on-vaccination-against-monkeypox?language=en."},{"key":"e_1_2_3_9_1","unstructured":"United States Food and Drug Administration (US FDA).Monkeypox Update: FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine Supply. US FDA. Published 9 August 2022. Available from URL:https:\/\/www.fda.gov\/news-events\/press-announcements\/monkeypox-update-fda-authorizes-emergency-use-jynneos-vaccine-increase-vaccine-supply."},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15623"},{"key":"e_1_2_3_11_1","unstructured":"NSW Health.Mpox (Monkeypox) Vaccination. NSW Government. Updated 3 August 2023. Available from URL:https:\/\/www.health.nsw.gov.au\/Infectious\/monkeypox\/Pages\/book-a-vaccine.aspx."},{"key":"e_1_2_3_12_1","unstructured":"ATAGI.ATAGI Recommendations on the Use of a Third Primary Dose of COVID\u201019 Vaccine in Individuals Who Are Severely Immunocompromised Version 4.2. Department of Health and Aged Care. Published 5 June 2023. Updated 6 June 2023. Available from URL:https:\/\/www.health.gov.au\/resources\/publications\/atagi-recommendations-on-the-use-of-a-third-primary-dose-of-covid-19-vaccine-in-individuals-who-are-severely-immunocompromised?language=en."},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.7683"},{"key":"e_1_2_3_14_1","article-title":"Accessing first doses of mpox vaccine made available in Victoria, Australia","volume":"31","author":"Chow EP","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"e_1_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00015-4"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7149a4"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.16386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T09:01:39Z","timestamp":1718614899000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.16386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1111\/imj.16386"],"URL":"https:\/\/doi.org\/10.1111\/imj.16386","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]},"assertion":[{"value":"2023-10-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}